Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Registration Rights Agreement (Bay Bancorp, Inc.), Securities Purchase Agreement (Bay Bancorp, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Company is in material compliance with all applicable NASDAQ National Market continued listing requirementsrequirements and is in good standing on such exchange. There are no proceedings pending or, to the Company’s Knowledge's knowledge, threatened against the Company relating to the continued listing of the Common Stock on the NASDAQ National Market and the Company has not received any notice of, nor to the Company’s Knowledge knowledge of the Company is there any basis for, the delisting of the Common Stock from NASDAQthe NASDAQ National Market.
Appears in 2 contracts
Samples: Redemption and Exchange Agreement (Genome Therapeutics Corp), Redemption and Exchange Agreement (Genome Therapeutics Corp)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s Knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Selecta Biosciences Inc), Securities Purchase Agreement (Selecta Biosciences Inc)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable NASDAQ continued listing requirementsrequirements of NASDAQ. There are no proceedings pending or, to the Company’s Knowledgeknowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Double Eagle Acquisition Corp.), Subscription Agreement (WillScot Corp)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, (a) the Company is in compliance with applicable NASDAQ Capital Market (the “NASDAQ”) continued listing requirements. There , (b) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Company Common Stock on NASDAQ NASDAQ, and (c) the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Company Common Stock from NASDAQ.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Sphere 3D Corp), Agreement and Plan of Merger (Overland Storage Inc)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, (i) the Company is in compliance with applicable NASDAQ Nasdaq continued listing requirements. There , (ii) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq, and (iii) the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.
Appears in 2 contracts
Samples: Exchange Agreement, Exchange Agreement (Turtle Beach Corp)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Documents, the Company is in compliance with applicable NASDAQ continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge's knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s Knowledge 's knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.. 4.15
Appears in 1 contract
Samples: Securities Purchase Agreement (Puissance Cross-Border Opportunities III LLC)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor nor, to the Company’s Knowledge Knowledge, is there any reasonable basis for, the delisting of the Common Stock from NASDAQNASDAQ that has not been remedied.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as described in the SEC Filings or on Schedule 4.20, (i) the Company is in compliance with applicable NASDAQ continued listing requirements. There requirements of The Nasdaq Global Market or The Nasdaq Capital Market ("Nasdaq"), (ii) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and (iii) the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as set forth in the Reference SEC Reports, the Company is in compliance with applicable NASDAQ continued listing requirements. There Except as set forth in the Reference SEC Reports, there are no proceedings pending or, to the knowledge of the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s Knowledge knowledge of the Company is there any basis for, the delisting of the Common Stock from NASDAQ.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ continued listing requirementsrequirements of the NASDAQ. There are no proceedings pending or, to the Company’s Knowledgeknowledge, threatened against the Company relating to the continued listing of the Common Stock on the NASDAQ and the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from the NASDAQ.
Appears in 1 contract
Samples: Stock Purchase Agreement (KalVista Pharmaceuticals, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ continued listing requirementsrequirements of The NASDAQ Stock Market. There are no proceedings pending or, to the Company’s Knowledgeknowledge, threatened against the Company relating to the continued listing of the Company Common Stock on The NASDAQ Global Market and the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from NASDAQThe NASDAQ Global Market.
Appears in 1 contract
Samples: Purchase Agreement (Glu Mobile Inc)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, (i) the Company is in compliance with applicable NASDAQ Nasdaq continued listing requirements. There , (ii) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq, and (iii) the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from NASDAQNasdaq. The Company reasonably believes that it will regain compliance with applicable Nasdaq continued listing requirements following the closing of this Transaction.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Documents, the Company is in compliance with applicable NASDAQ continued listing requirements. There are no proceedings pending or, to the Company’s Knowledgeknowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and the Company has not received any notice of, nor to the Company’s Knowledge knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQ.
Appears in 1 contract
Samples: Securities Purchase Agreement (Bellerophon Therapeutics, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable NASDAQ Stock Market, LLC continued listing requirements. There are no proceedings pending or, to the Company’s Knowledgeknowledge, threatened against the Company relating to the continued listing of the Common Stock on The NASDAQ Global Select Market and the Company has not received any notice of, nor to the Company’s Knowledge knowledge is there any reasonable basis for, the delisting of the Common Stock from NASDAQThe NASDAQ Global Select Market.
Appears in 1 contract
Samples: Securities Purchase Agreement (Aimmune Therapeutics, Inc.)
Compliance with Nasdaq Continued Listing Requirements. The Except as described in the SEC Filings, (a) the Company is in compliance with applicable NASDAQ Nasdaq continued listing requirements. There , (b) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ and Nasdaq, (c) the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from NASDAQNasdaq and (d) the Company has taken no action designed to terminate, or likely to have the effect of terminating, the listing of the Common Stock.
Appears in 1 contract
Samples: Financial Advisory Agreement (Overland Storage Inc)
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, (i) the Company is in compliance with applicable NASDAQ Nasdaq continued listing requirements. There , (ii) there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq, and (ii) the Company has not received any currently pending notice of, nor to the Company’s Knowledge is there any basis for, of the delisting of the Common Stock from NASDAQNasdaq.
Appears in 1 contract
Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, the Company is in compliance with applicable NASDAQ Nasdaq continued listing requirements. There Except as disclosed in the SEC Filings, there are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the Common Stock on NASDAQ Nasdaq and the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from NASDAQNasdaq.
Appears in 1 contract
